Page 266 - 73_04

MARIANO ESTEBAN RODRÍGUEZ ANAL. REAL ACAD. NAC. FARM.

(6) LETVIN, N.L. (2006) Progress and obstacles in the development of an AIDS
(7) vaccine. Nat. Rev. Immunol. 6 (12): 930-9.
(8) ALCAMI, J.; JOSEPH MUNNE, J.; MUNOZ-FERNANDEZ, M.A. Y ESTEBAN, M. (2005)
Current situation in the development of a preventive HIV vaccine. Enferm.
(9) Infecc. Microbiol. Clin. 23 (Supl. 2): 15-24.
(10) GONZALO, R.M.; RODRIGUEZ, J.R.; RODRIGUEZ, D.; GONZALEZ-ASEGUINOLAZA, G.;
(11) LARRAGA, V. AND ESTEBAN, M. (2001) Protective immune response against cu-
(12) taneous leishmaniasis by prime/booster immunization regimens with vacci-
nia virus recombinants expressing Leishmania infantum p36/LACK and IL-12
(13) in combination with purified p36. Microbes Infect. 3 (9): 701-11.
(14) MOSS, B. (1996) Genetically engineered poxviruses for recombinant gene
expression, vaccination, and safety. Proc. Natl. Acad. Sci. USA. 93 (21): 11341-
(15) 8.
(16) STAIB, C.; DREXLER, I. AND SUTTER, G. (2004) Construction and isolation of
(17) recombinant MVA. Methods Mol. Biol. 269: 77-100.
(18) PASTORET, P.P. AND VANDERPLASSCHEN, A. (2003) Poxviruses as vaccine vectors.
Comp. Immunol. Microbiol. Infect. Dis. 26 (5-6): 343-55.
MAYR, A.; STICKL, H.; MULLER, H.K.; DANNER, K. AND SINGER, H. (1978) [The
smallpox vaccination strain MVA: marker, genetic structure, experience gai-
ned with the parenteral vaccination and behavior in organisms with a debi-
litated defence mechanism (author’s transl)]. Zentralbl. Bakteriol. [B]. 167 (5-
6): 375-90.
SUTTER, G. AND STAIB, C. (2003) Vaccinia vectors as candidate vaccines: the
development of modified vaccinia virus Ankara for antigen delivery. Curr.
Drug Targets Infect. Disord. 3 (3): 263-71.
LI, S.; RODRIGUES, M.; RODRIGUEZ, D.; RODRIGUEZ, J.R.; ESTEBAN, M.; PALESE,
P. ET AL. (1994) Priming with recombinant influenza virus followed by ad-
ministration of recombinant vaccinia virus induces CD8+ T-cell-mediated
protective immunity against malaria. Proc. Natl. Acad. Sci. USA. 90 (11):
5214-8.
RODRIGUES, M.; LI, S.; MURATA, K.; RODRIGUEZ, D.; RODRIGUEZ, J.R.; BACIK, I. ET
AL. (1994) Influenza and vaccinia viruses expressing malaria CD8+ T and B
cell epitopes. Comparison of their immunogenicity and capacity to induce
protective immunity. J. Immunol. 153 (10): 4636-48.
MIYAHIRA, Y.; GARCIA-SASTRE, A.; RODRIGUEZ, D.; RODRIGUEZ, J.R.; MURATA, K.;
TSUJI, M. ET AL. (1998) Recombinant viruses expressing a human malaria
antigen can elicit potentially protective immune CD8+ responses in mice.
Proc. Natl. Acad. Sci. USA. 95 (7): 3954-9.
ZAVALA, F.; RODRIGUES, M.; RODRIGUEZ, D.; RODRIGUEZ, J.R.; NUSSENZWEIG, R.S.
AND ESTEBAN, M. (2001) A striking property of recombinant poxviruses: effi-
cient inducers of in vivo expansion of primed CD8(+) T cells. Virology. 280
(2): 155-9.
GHERARDI, M.M.; PEREZ-JIMENEZ, E.; NAJERA, J.L. AND ESTEBAN M. (2004) Induc-
tion of HIV immunity in the genital tract after intranasal delivery of a MVA
vector: enhanced immunogenicity after DNA prime-modified vaccinia virus
Ankara boost immunization schedule. J. Immunol. 172 (10): 6209-20.

1076